Annual EBITDA:
-$150.57M-$50.04M(-49.77%)Summary
- As of today, VKTX annual EBITDA is -$150.57 million, with the most recent change of -$50.04 million (-49.77%) on December 31, 2024.
- During the last 3 years, VKTX annual EBITDA has fallen by -$95.19 million (-171.86%).
- VKTX annual EBITDA is now -148836.70% below its all-time high of -$101.10 thousand, reached on December 31, 2013.
Performance
VKTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$98.45M-$23.98M(-32.21%)Summary
- As of today, VKTX quarterly EBITDA is -$98.45 million, with the most recent change of -$23.98 million (-32.21%) on September 30, 2025.
- Over the past year, VKTX quarterly EBITDA has dropped by -$61.98 million (-169.95%).
- VKTX quarterly EBITDA is now -3076368.75% below its all-time high of -$3200.00, reached on March 31, 2013.
Performance
VKTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$274.39M-$61.98M(-29.18%)Summary
- As of today, VKTX TTM EBITDA is -$274.39 million, with the most recent change of -$61.98 million (-29.18%) on September 30, 2025.
- Over the past year, VKTX TTM EBITDA has dropped by -$140.74 million (-105.30%).
- VKTX TTM EBITDA is now -250260.40% below its all-time high of -$109.60 thousand, reached on December 31, 2012.
Performance
VKTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
VKTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -49.8% | -169.9% | -105.3% |
| 3Y3 Years | -171.9% | -513.2% | -340.5% |
| 5Y5 Years | -364.4% | -907.3% | -779.7% |
VKTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -171.9% | at low | -513.2% | at low | -340.5% | at low |
| 5Y | 5-Year | -364.4% | at low | -907.3% | at low | -779.7% | at low |
| All-Time | All-Time | >-9999.0% | at low | >-9999.0% | at low | >-9999.0% | at low |
VKTX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$98.45M(-32.2%) | -$274.39M(-29.2%) |
| Jun 2025 | - | -$74.46M(-34.5%) | -$212.42M(-23.5%) |
| Mar 2025 | - | -$55.36M(-20.0%) | -$171.93M(-14.2%) |
| Dec 2024 | -$150.57M(-49.8%) | -$46.13M(-26.5%) | -$150.57M(-12.7%) |
| Sep 2024 | - | -$36.47M(-7.3%) | -$133.66M(-7.5%) |
| Jun 2024 | - | -$33.98M(+0.1%) | -$124.38M(-9.0%) |
| Mar 2024 | - | -$34.00M(-16.4%) | -$114.07M(-13.5%) |
| Dec 2023 | -$100.53M(-43.5%) | -$29.21M(-7.4%) | -$100.53M(-9.8%) |
| Sep 2023 | - | -$27.19M(-14.9%) | -$91.53M(-13.9%) |
| Jun 2023 | - | -$23.67M(-15.6%) | -$80.40M(-8.1%) |
| Mar 2023 | - | -$20.46M(-1.3%) | -$74.36M(-6.1%) |
| Dec 2022 | -$70.06M(-26.5%) | -$20.21M(-25.9%) | -$70.06M(-12.5%) |
| Sep 2022 | - | -$16.05M(+8.9%) | -$62.29M(-4.6%) |
| Jun 2022 | - | -$17.63M(-9.0%) | -$59.56M(-3.8%) |
| Mar 2022 | - | -$16.17M(-30.0%) | -$57.40M(-3.6%) |
| Dec 2021 | -$55.39M(-30.7%) | -$12.43M(+6.7%) | -$55.39M(-2.3%) |
| Sep 2021 | - | -$13.33M(+13.8%) | -$54.15M(-7.0%) |
| Jun 2021 | - | -$15.47M(-9.3%) | -$50.59M(-10.8%) |
| Mar 2021 | - | -$14.16M(-26.5%) | -$45.66M(-7.7%) |
| Dec 2020 | -$42.38M(-30.7%) | -$11.19M(-14.5%) | -$42.38M(-35.9%) |
| Sep 2020 | - | -$9.77M(+7.3%) | -$31.19M(-8.1%) |
| Jun 2020 | - | -$10.54M(+3.1%) | -$28.86M(-3.5%) |
| Mar 2020 | - | -$10.88M | -$27.89M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$32.43M(-24.0%) | - | - |
| Sep 2019 | - | -$7.44M(+22.3%) | -$30.85M(-31.8%) |
| Jun 2019 | - | -$9.57M(-40.6%) | -$23.41M(-69.1%) |
| Mar 2019 | - | -$6.81M(+3.3%) | -$13.84M(-16.9%) |
| Dec 2018 | -$26.16M(-37.2%) | -$7.04M(-46.5%) | -$11.84M(+37.4%) |
| Mar 2018 | - | -$4.80M(-8.5%) | -$18.91M(+0.9%) |
| Dec 2017 | -$19.07M(-37.7%) | -$4.43M(+5.6%) | -$19.07M(-3.8%) |
| Sep 2017 | - | -$4.69M(+5.8%) | -$18.38M(-8.4%) |
| Jun 2017 | - | -$4.98M(-0.3%) | -$16.95M(-9.0%) |
| Mar 2017 | - | -$4.97M(-32.9%) | -$15.55M(-12.3%) |
| Dec 2016 | -$13.85M(-15.4%) | -$3.74M(-14.5%) | -$13.85M(+6.0%) |
| Sep 2016 | - | -$3.26M(+8.8%) | -$14.73M(-28.5%) |
| Jun 2016 | - | -$3.58M(-9.5%) | -$11.47M(-9.0%) |
| Mar 2016 | - | -$3.27M(+29.3%) | -$10.51M(-45.1%) |
| Dec 2015 | -$12.00M(+48.9%) | -$4.62M(-75.9%) | -$7.25M(-175.9%) |
| Jun 2015 | - | -$2.63M(+87.9%) | -$2.63M(+88.0%) |
| Dec 2014 | -$23.47M(>-9900.0%) | - | - |
| Jun 2014 | - | -$21.76M(>-9900.0%) | -$21.89M(>-9900.0%) |
| Mar 2014 | - | -$131.50K(-673.5%) | -$148.50K(-14.4%) |
| Dec 2013 | -$101.10K(+7.8%) | - | - |
| Jun 2013 | - | -$17.00K(-431.3%) | -$129.80K(-15.1%) |
| Mar 2013 | - | -$3200.00(+97.1%) | -$112.80K(-2.9%) |
| Dec 2012 | -$109.60K | -$109.60K | -$109.60K |
FAQ
- What is Viking Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Viking Therapeutics, Inc.?
- What is Viking Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Viking Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Viking Therapeutics, Inc.?
- What is Viking Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Viking Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Viking Therapeutics, Inc.?
- What is Viking Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Viking Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of VKTX is -$150.57M
What is the all-time high annual EBITDA for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high annual EBITDA is -$101.10K
What is Viking Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, VKTX annual EBITDA has changed by -$50.04M (-49.77%)
What is Viking Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of VKTX is -$98.45M
What is the all-time high quarterly EBITDA for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high quarterly EBITDA is -$3200.00
What is Viking Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, VKTX quarterly EBITDA has changed by -$61.98M (-169.95%)
What is Viking Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of VKTX is -$274.39M
What is the all-time high TTM EBITDA for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high TTM EBITDA is -$109.60K
What is Viking Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, VKTX TTM EBITDA has changed by -$140.74M (-105.30%)